The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Resminostat in advanced hepatocellular carcinoma (HCC): Overall survival subgroup analysis of prognostic factors in the SHELTER trial.
Michael Bitzer
Honoraria - 4SC A
Tom M. Ganten
No relevant relationships to disclose
Marcus A. Woerns
Consultant or Advisory Role - Bayer
Jens T. Siveke
No relevant relationships to disclose
Matthias M. Dollinger
Consultant or Advisory Role - Bayer
Research Funding - Bayer
Max E. Scheulen
No relevant relationships to disclose
Henning Wege
No relevant relationships to disclose
Edoardo G. Giannini
Consultant or Advisory Role - 4SC AG
Research Funding - 4SC AG
Umberto Cillo
No relevant relationships to disclose
Franco Trevisani
Consultant or Advisory Role - Bayer
Research Funding - Bayer
Armando Santoro
No relevant relationships to disclose
Vincenzo Montesarchio
No relevant relationships to disclose
Anna Mais
Employment or Leadership Position - 4SC AG
Bernhard Hauns
Employment or Leadership Position - 4SC AG
Julia Asche
Employment or Leadership Position - 4SC A
Thomas Herz
Employment or Leadership Position - 4SC AG
Stefano Pegoraro
Employment or Leadership Position - 4SC AG
Aldo Ammendola
Employment or Leadership Position - 4SC AG
Stefan W. Henning
Employment or Leadership Position - 4SC AG
Stock Ownership - 4SC AG
Bernd Hentsch
Employment or Leadership Position - 4SC AG
Stock Ownership - 4SC AG